Abstract
The aim of this study was to evaluate and characterize the feasibility and safety of bone marrow-derived cell (BMC) mobilization following repeated courses of granulocyte-colony stimulating factor (G-CSF) in patients with amyotrophic lateral sclerosis (ALS).
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 50-59 |
| Numero di pagine | 10 |
| Rivista | Cytotherapy |
| Volume | 12 |
| Numero di pubblicazione | 1 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2010 |
Keywords
- Adult
- Amyotrophic Lateral Sclerosis
- Antigens
- Biological Markers
- Bone Marrow Cells
- CD34
- Cell Differentiation
- Cell Lineage
- Cell Movement
- Colony-Forming Units Assay
- Drug Administration Schedule
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor
- Hematopoietic Stem Cell Mobilization
- Hematopoietic Stem Cells
- Humans
- Male
- Middle Aged
- Nerve Regeneration
- Neuroglia
- Neurons
- Prospective Studies
- Stem Cells
- Treatment Outcome
Fingerprint
Entra nei temi di ricerca di 'Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver